JP2001527523A5 - - Google Patents

Download PDF

Info

Publication number
JP2001527523A5
JP2001527523A5 JP1998521930A JP52193098A JP2001527523A5 JP 2001527523 A5 JP2001527523 A5 JP 2001527523A5 JP 1998521930 A JP1998521930 A JP 1998521930A JP 52193098 A JP52193098 A JP 52193098A JP 2001527523 A5 JP2001527523 A5 JP 2001527523A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998521930A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001527523A (ja
Filing date
Publication date
Priority claimed from US08/857,811 external-priority patent/US6506783B1/en
Application filed filed Critical
Publication of JP2001527523A publication Critical patent/JP2001527523A/ja
Publication of JP2001527523A5 publication Critical patent/JP2001527523A5/ja
Ceased legal-status Critical Current

Links

JP52193098A 1997-05-16 1997-11-26 ウイルス感染および癌の治療のためのベンゾイミダゾール−２−カーバメート Ceased JP2001527523A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/857,811 1997-05-16
US08/857,811 US6506783B1 (en) 1997-05-16 1997-05-16 Cancer treatments and pharmaceutical compositions therefor
PCT/US1997/021565 WO1998051304A1 (en) 1997-05-16 1997-11-26 Benzimidazole-2-carbamates for the treatment of viral infections and cancer

Publications (2)

Publication Number Publication Date
JP2001527523A JP2001527523A (ja) 2001-12-25
JP2001527523A5 true JP2001527523A5 (enExample) 2005-06-16

Family

ID=25326784

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52193098A Ceased JP2001527523A (ja) 1997-05-16 1997-11-26 ウイルス感染および癌の治療のためのベンゾイミダゾール−２−カーバメート

Country Status (22)

Country Link
US (13) US6506783B1 (enExample)
EP (1) EP0956017B1 (enExample)
JP (1) JP2001527523A (enExample)
KR (1) KR20000049065A (enExample)
CN (1) CN1254282A (enExample)
AR (1) AR010008A1 (enExample)
AT (1) ATE363904T1 (enExample)
AU (1) AU728690B2 (enExample)
BR (1) BR9714634A (enExample)
CA (1) CA2268840C (enExample)
CZ (1) CZ125299A3 (enExample)
DE (1) DE69737793D1 (enExample)
HU (1) HUP0001170A3 (enExample)
IL (1) IL129352A0 (enExample)
NO (1) NO991700L (enExample)
NZ (1) NZ335159A (enExample)
PE (1) PE11099A1 (enExample)
PL (1) PL335541A1 (enExample)
SK (1) SK47099A3 (enExample)
TR (1) TR199901528T2 (enExample)
WO (1) WO1998051304A1 (enExample)
ZA (1) ZA979096B (enExample)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) * 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) * 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6384049B1 (en) * 2000-05-25 2002-05-07 The Procter & Gamble Company Cancer treatment
US6462062B1 (en) * 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) * 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
AU2002239395A1 (en) * 2000-11-01 2002-06-03 The Procter And Gamble Company Hiv treatment with benzimidazoles
PT1347743E (pt) * 2000-12-07 2006-06-30 Univ Utrecht Holding Bv Composicao para o tratamento de doencas inflamatorias
US7423015B1 (en) 2001-01-11 2008-09-09 Board Of Regents, The University Of Texas System Antihelminthic drugs as a treatment for hyperproliferative diseases
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
US6693125B2 (en) * 2001-01-24 2004-02-17 Combinatorx Incorporated Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
AUPR626001A0 (en) * 2001-07-10 2001-08-02 Mcgregor, Neil A method of treatment and/or prophylaxis
EP1429713A4 (en) * 2001-09-24 2007-08-08 Jessie L S Au METHOD AND COMPOSITIONS FOR DETERMINING THE CHEMOSENSIBILIZING DOSAGE OF SURAMINE IN COMBINATION THERAPY
AU2003220585A1 (en) * 2002-03-26 2003-10-13 Arizona Board of Regents on behalf of the University of Arizone Solubilization of weak bases
US20050152962A1 (en) * 2002-06-12 2005-07-14 Metselaar Josbert M. Composition for treatment of inflammatory disorders
US8492443B2 (en) * 2002-07-08 2013-07-23 Joe S. Wilkins, Jr. Treatment for herpes simplex virus and other infectious diseases
EP1393720A1 (en) * 2002-08-27 2004-03-03 Universiteit Utrecht Vesicle-encapsulated corticosteroids for treatment of cancer
AU2003900064A0 (en) * 2003-01-09 2003-01-23 Penam Investments Pty. Ltd. A method of treatment or prophylaxis of viral infection.
US7381825B2 (en) 2003-03-17 2008-06-03 Takeda San Diego, Inc. Histone deacetylase inhibitors
EP1598353A1 (en) * 2004-05-17 2005-11-23 Boehringer Ingelheim International GmbH Pyrrolobenzimidazolones and their use as antiproliferative agents
JP2008515956A (ja) * 2004-10-12 2008-05-15 ノボ ノルディスク アクティーゼルスカブ １１β−ヒドロキシステロイドデヒドロゲナーゼ１型活性スピロ化合物
US7193254B2 (en) * 2004-11-30 2007-03-20 International Business Machines Corporation Structure and method of applying stresses to PFET and NFET transistor channels for improved performance
PT1830847E (pt) 2004-12-06 2015-02-05 Pitney Pharmaceuticals Pty Ltd Tratamento para o cancro
CA2593714C (en) 2005-02-04 2013-09-10 Survac Aps Survivin peptide vaccine
US7265248B1 (en) 2005-04-29 2007-09-04 Technology Innovations, Llc Compositions and methods for the treatment of malaria
EA200801492A1 (ru) * 2005-11-01 2008-10-30 Транстек Фарма Фармацевтическое применение замещенных амидов
AU2006310518A1 (en) * 2005-11-01 2007-05-10 High Point Pharmaceuticals, Llc Pharmaceutical use of substituted amides
AU2006312407A1 (en) * 2005-11-09 2007-05-18 Philera New Zealand Limited Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits
CA2642813A1 (en) * 2006-02-28 2007-09-07 Merck & Co., Inc. Inhibitors of histone deacetylase
CA2646588A1 (en) * 2006-03-21 2007-09-27 High Point Pharmaceuticals, Llc Adamantane derivatives for the treatment of the metabolic syndrome
AU2007236049A1 (en) 2006-04-07 2007-10-18 High Point Pharmaceuticals, Llc 11beta-hydroxysteroid dehydrogenase type 1 active compounds
WO2007146811A2 (en) * 2006-06-09 2007-12-21 University Of Miami Assessment of cellular composition and fractional viability and uses thereof
EP2038255A2 (en) * 2006-06-16 2009-03-25 High Point Pharmaceuticals, LLC Pharmaceutical use of substituted piperidine carboxamides
EP1878721A1 (en) * 2006-07-13 2008-01-16 Novo Nordisk A/S 4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
US8048908B2 (en) * 2006-07-13 2011-11-01 High Point Pharmaceuticals, Llc 11β-hydroxysteroid dehydrogenase type 1 active compounds
EP2150526B1 (en) * 2007-02-23 2017-09-20 vTv Therapeutics LLC N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
EP2129652A2 (en) * 2007-02-23 2009-12-09 High Point Pharmaceuticals, LLC N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
WO2008101886A1 (en) * 2007-02-23 2008-08-28 High Point Pharmaceuticals, Llc N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
JP2010519239A (ja) * 2007-02-23 2010-06-03 ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー １１−ベータ−ヒドロキシステロイドデヒドロゲナーゼの阻害因子としてのｎ−アドマンチルベンザミド
KR20100015414A (ko) * 2007-03-09 2010-02-12 하이 포인트 파마슈티칼스, 엘엘씨 히드록시스테로이드 탈수소효소 억제제로서 인돌- 및 벤즈이미다졸 아미드
US20100056600A1 (en) * 2007-03-28 2010-03-04 Soren Ebdrup 11beta-hsd1 active compounds
CN101677562A (zh) * 2007-04-11 2010-03-24 高点制药有限责任公司 新化合物
CA2685036A1 (en) * 2007-04-24 2008-11-06 High Point Pharmaceuticals, Llc Pharmaceutical use of substituted amides
WO2009002495A1 (en) * 2007-06-27 2008-12-31 Merck & Co., Inc. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
US8461189B2 (en) * 2007-06-27 2013-06-11 Merck Sharp & Dohme Corp. Pyridyl derivatives as histone deacetylase inhibitors
US8835506B2 (en) 2008-06-05 2014-09-16 Stc.Unm Methods and related compositions for the treatment of cancer
US8771693B2 (en) 2009-10-27 2014-07-08 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
WO2012015715A1 (en) 2010-07-27 2012-02-02 High Point Pharmaceuticals, Llc Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta hsd1 modulators
WO2012149334A2 (en) 2011-04-27 2012-11-01 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
MA37610B1 (fr) 2012-05-09 2017-07-31 Univ Western Health Sciences Formulations de testostérone proliposomales
WO2014082085A1 (en) * 2012-11-26 2014-05-30 The University Of North Carolina At Chapel Hill Use of itk inhibitors for the treatment of cancer
WO2016077648A1 (en) * 2014-11-11 2016-05-19 Neymeyer Calvin E Method of treating pre-cancerous lesion with glyphosate, and compositions thereof
WO2016187767A1 (en) * 2015-05-25 2016-12-01 Hutchison Medipharma Limited Pharmaceutical compositions and use thereof
WO2018081361A1 (en) * 2016-10-28 2018-05-03 Children's Hospital Medical Center Methods and compositions for treatment of myelodyspastic syndromes and/or acute myleoid leukemias
CN109633026A (zh) * 2019-01-03 2019-04-16 上海市农业科学院 一种液相色谱-串联质谱检测多菌灵及其代谢物的方法
EP3907230B1 (en) 2020-03-30 2024-08-28 Biometrix Technology Inc. Novel benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent comprising the same
KR102583547B1 (ko) 2020-03-30 2023-10-06 (주)바이오메트릭스 테크놀로지 신규한 벤지미다졸 유도체, 이의 제조방법 및 이의 항암제 용도
KR102449266B1 (ko) 2020-06-23 2022-09-30 (주)바이오메트릭스 테크놀로지 항암 활성 그리고 항바이러스 활성을 갖는 신규한 벤지미다졸-탄수화물 결합체 화합물(Benzimidazole carbohydrate conjugate compound) 및 이의 제조 방법
CN114096549A (zh) 2020-06-23 2022-02-25 博美利克斯技术公司 新型苯并咪唑衍生物、其制备方法及其作为抗癌剂或者抗病毒剂的用途
KR102342313B1 (ko) 2021-08-27 2021-12-24 (주)바이오메트릭스 테크놀로지 벤지미다졸-탄수화물 결합체 화합물을 포함하는 미셀, 이의 제조방법, 이의 항암제 또는 항바이러스제로서의 용도

Family Cites Families (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE136499C (enExample)
DE158398C (enExample)
US2933502A (en) * 1958-02-12 1960-04-19 Du Pont Benzimidazolone derivatives
US3010968A (en) 1959-11-25 1961-11-28 Du Pont Process for manufacture of certain alkyl esters of benzimidazole carbamic acids
NL134354C (enExample) 1963-05-23
US3499761A (en) 1964-07-20 1970-03-10 Gaf Corp Silver halide emulsions containing alkyl esters of benzimidazole carbamic acid antifogging agents
BE666795A (enExample) 1964-08-04 1966-01-13
USRE28403E (en) 1964-08-04 1975-04-29 Butyl and n-propoxy-z-carbo- methoxyaminobenzimidazoles
US3541213A (en) 1966-05-06 1970-11-17 Du Pont Fungicidal and mite ovicidal substituted 2-aminobenzimidazoles
US3399212A (en) * 1966-05-16 1968-08-27 Smith Kline French Lab Benzimidazole ureas
US3480642A (en) * 1967-03-22 1969-11-25 Smithkline Corp Process for producing 2-carbalkoxyaminobenzimidazoles
US3881014A (en) 1968-11-05 1975-04-29 Bayer Ag N-tritylimidazoles for treating fungal infections
BE744970A (fr) 1969-01-28 1970-07-27 Lilly Co Eli Agents antiviraux et immuno-depresseurs
BE759337A (fr) 1969-11-24 1971-05-24 Lilly Co Eli Benzimidazol (2,1-b)-quinazolin (6h) ones qui sont des immuno-depresseurs, et nouvelles benzimidazo (2,1-b) quinazolin-12-(6h) ones
FR2046114A5 (en) 1970-01-30 1971-03-05 Dynachim Sarl Benzimidazole derivs anthelmintic, antifung - al bactericidal, aericidal, insecticidal, nema
US3956262A (en) 1970-12-09 1976-05-11 Beecham Group Limited Triazenoimidazoles
US3738995A (en) 1971-05-14 1973-06-12 Du Pont Solvent process for the preparation of 1 - carbamoyl-substituted 2 - benzimidazolecarbamates
DE2144505A1 (de) 1971-09-06 1973-03-15 Boehringer Sohn Ingelheim S-triazino- eckige klammer auf 1,2-a eckige klammer zu-benzimidazole
FR2155888A1 (en) 1971-10-13 1973-05-25 Agot Aime Solid anthelmintic composn - for more economical treatment of ruminants
DE2227919C2 (de) * 1972-06-08 1982-12-23 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Benzimidazol-2-yl-carbaminsäure-methylester
DE2253324A1 (de) 1972-10-31 1974-05-09 Bayer Ag 1-alkoxycarbonyl-2- eckige klammer auf bis-(alkoxycarbonyl)-amino eckige klammer zu -benzimidazole, verfahren zu ihrer herstellung, sowie ihre verwendung als fungizide
US4046906A (en) 1973-04-21 1977-09-06 Hoechst Aktiengesellschaft Salts of alkyl 2-benzimidazole-carbamate
JPS5142565A (en) 1974-10-09 1976-04-10 Copal Co Ltd onnoff taimaa
US4001423A (en) * 1975-06-20 1977-01-04 Dodds Dale I 2-(2-ethoxy)ethoxyethyl benzimidazolecarbamate
DE2527677A1 (de) * 1975-06-21 1977-01-20 Bayer Ag Verfahren zur herstellung von 2,4- dioxo-1,2,3,4-tetrahydro-s-triazino- eckige klammer auf 1,2-a eckige klammer zu -benzimidazolen
US4086235A (en) 1976-04-12 1978-04-25 Syntex (U.S.A.) Inc. 5 (6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
IN159210B (enExample) 1982-01-11 1987-04-11 Council Scient Ind Res
IN158878B (enExample) 1982-07-15 1987-02-07 Council Scient Ind Res
HU193951B (en) 1985-03-11 1987-12-28 Richter Gedeon Vegyeszet Process for producing new sulfur-containing 5-substituted benzimidazol derivatives and pharmaceutical compositions containing them
US4731366A (en) 1986-08-05 1988-03-15 Harbor Branch Oceanographic Institution, Inc. Discorhabdin compositions and their methods of use
GB2210875B (en) 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
US5329012A (en) 1987-10-29 1994-07-12 The Research Foundation Of State University Of New York Bis(acyloxmethyl)imidazole compounds
US5114951A (en) 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
US5149527A (en) 1990-09-18 1992-09-22 Oncotech, Inc. Immunopotentiating protocol for chemotherapy-responsive tumors
US5284662A (en) 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
JPH04223274A (ja) 1990-12-26 1992-08-13 Kansei Corp 加速度センサ
GB9106278D0 (en) 1991-03-25 1991-05-08 Smithkline Beecham Plc Method of treatment
US5364875A (en) 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
US5310748A (en) 1992-05-11 1994-05-10 The Du Pont Merck Pharmaceutical Company Imidazoles for the treatment of atherosclerosis
US5290801A (en) 1992-05-29 1994-03-01 The Du Pont Merck Pharmaceutical Company Benzimidazoles for the treatment of atherosclerosis
WO1994004541A2 (en) 1992-08-12 1994-03-03 The Upjohn Company Protein kinase inhibitors and related compounds combined with taxol
FR2703057B1 (fr) 1993-03-24 1995-06-16 Elysees Balzac Financiere Matériau alvéolaire cellulosique renfermant un agent biocide et procédé pour sa préparation.
CZ286412B6 (en) 1993-03-31 2000-04-12 Merck & Co Inc Synergetic combination of compounds for treating AIDS, pharmaceutical preparation containing such synergetic combination and use of this synergetic combination for preparing pharmaceutical preparation
US5434163A (en) 1993-05-14 1995-07-18 The Medical College Of Pennsylvania Treatment of Cryptococcus neoformans infection
US5554373A (en) 1993-11-05 1996-09-10 Seabrook; Samuel G. Compositions containing anti-microbial agents and methods for making and using same
JP3213471B2 (ja) 1994-04-13 2001-10-02 ポーラ化成工業株式会社 薬効成分含有リポソーム製剤の製造方法
US6177460B1 (en) * 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
ZA962879B (en) * 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) * 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
DE69637178D1 (de) 1995-04-12 2007-09-06 Uaf Technologies And Res Llc N-chlorphenylcarbamate enthaltendes arzneimittel sowie n-chlorphenylthiocarbamate zur hemmung des wachstums von viren
US6479526B1 (en) * 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US5665713A (en) 1995-04-12 1997-09-09 Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
ZA962880B (en) 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
NZ305784A (en) 1995-04-12 2001-03-30 Procter & Gamble Benzimidazole containing medicaments for treating cancers, tumors and viral infections
US5629341A (en) 1995-04-12 1997-05-13 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US5656615A (en) 1995-04-12 1997-08-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals
US5665751A (en) 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6200992B1 (en) * 1995-06-07 2001-03-13 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
CZ391197A3 (cs) 1995-06-07 1998-05-13 The Procter & Gamble Company Použití benzimidazolů pro přípravu léčiva pro léčení leukémie
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US20010039291A1 (en) * 1995-06-07 2001-11-08 The Procter & Gamble Company Compositions and methods of treatment for cancer or viral infections
MX9707809A (es) * 1995-06-07 1998-01-31 Procter & Gamble Una composicion farmaceutica que contiene bencimidazol para inhibir el crecimiento de canceres.
US6265427B1 (en) * 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
MX9800945A (es) 1995-08-03 1998-04-30 Procter & Gamble Uso de griseofulvina para inhibir el crecimiento de canceres.
MX9707808A (es) * 1995-08-04 1998-01-31 Procter & Gamble Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres.
PL324904A1 (en) 1995-08-04 1998-06-22 Procter & Gamble Application of fluconazole in carcinoma development inhibition
US6686391B2 (en) * 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5908855A (en) 1996-07-16 1999-06-01 The Procter & Gamble Company Compositions for treating viral infections
AU6966696A (en) * 1995-10-05 1997-04-28 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
US5627094A (en) * 1995-12-04 1997-05-06 Chartered Semiconductor Manufacturing Pte, Ltd. Stacked container capacitor using chemical mechanical polishing
US6541213B1 (en) * 1996-03-29 2003-04-01 University Of Washington Microscale diffusion immunoassay
DE19623226A1 (de) * 1996-06-11 1997-12-18 Basf Ag Katalysatorsysteme vom Typ der Ziegler-Natta-Katalysatoren
US6056973A (en) * 1996-10-11 2000-05-02 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method of preparation
US5825811A (en) 1997-01-16 1998-10-20 Motorola, Inc. Method and apparatus for facilitating inbound channel access
US5900429A (en) * 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) * 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US5908885A (en) * 1997-07-01 1999-06-01 University Of South Alabama Polysuccinimide and polyaspartate as additives to cementitious materials
US6245789B1 (en) * 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
DE19842116C2 (de) 1998-09-07 2001-02-08 Schuelke & Mayr Gmbh Verwendung von Derivaten von Methylenbisoxazolidin und dadurch erhaltene Zusammensetzungen
US6248843B1 (en) * 1998-09-18 2001-06-19 Mcwhorter Technologies, Inc. Powder coatings based on branched oligoesters and triazole blocked polyisocyanates
EP1119345B1 (en) 1998-10-09 2009-04-29 General Mills, Inc. Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
US6211177B1 (en) * 1998-11-24 2001-04-03 Cell Pathways, Inc. Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivatives
US20010053773A1 (en) * 1998-12-22 2001-12-20 The Procter & Gamble Company Method for inhibiting the growth of cancers
ATE253354T1 (de) * 1999-02-23 2003-11-15 Yuhan Corp Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6136835A (en) * 1999-05-17 2000-10-24 The Procter & Gamble Company Methods of treatment for viral infections
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6135835A (en) * 1999-08-16 2000-10-24 Future Beach Corporation Aquatic vehicle
WO2001083457A2 (en) 2000-04-28 2001-11-08 The Procter & Gamble Company Benzimidazole-2-carbamates and their use in cancer treatment
US6384049B1 (en) * 2000-05-25 2002-05-07 The Procter & Gamble Company Cancer treatment
US6518269B1 (en) * 2000-07-28 2003-02-11 University Of Arizona Foundation Cancer treatment
US6290929B1 (en) 2000-07-28 2001-09-18 The Procter & Gamble Company Cancer treatment
US6407105B1 (en) * 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) * 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) * 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
AU2001292796B2 (en) 2000-09-26 2005-12-22 Uaf Technologies And Research Llc Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) * 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
AU2002239395A1 (en) 2000-11-01 2002-06-03 The Procter And Gamble Company Hiv treatment with benzimidazoles

Similar Documents

Publication Publication Date Title
JP2001510603A5 (enExample)
JP2002510982A5 (enExample)
JP2000501018A5 (enExample)
JP2000500076A5 (enExample)
JP2001504697A5 (enExample)
JP2002511159A5 (enExample)
JP2000501324A5 (enExample)
JP2001504009A5 (enExample)
JP2001501759A5 (enExample)
JP2000500055A5 (enExample)
JP2000500026A5 (enExample)
JP2001527523A5 (enExample)
JP2001503735A5 (enExample)
JP2000501338A5 (enExample)
JP2000500874A5 (enExample)
JP2000511728A5 (enExample)
JP2000502425A5 (enExample)
JP2000502568A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2000507133A5 (enExample)
JP2000501876A5 (enExample)
JP2001504291A5 (enExample)
JP2000508681A5 (enExample)
JP2001501236A5 (enExample)